Skip to main content

Key points

These guidelines are recommended for dosing, preparing and centrally administering inotropes and vasopressors in adults.

If central venous access is not possible, peripheral administration should be commenced in consultation with a critical care service, ARV or the tertiary referral hospital.

ARV 1300 368 661

On this page

    Please note that this guidance is currently undergoing review by Safer Care Victoria to ensure  the content is up to date. In the meantime, we recommend that you also refer to more contemporaneous evidence where possible.

    Prescribing guide

    The table below is an easy-to-follow prescribing guide for emergency clinicians to use when managing patients who require inotropes and vasopressors.

    Click on the links for more detailed information on each medication.

    Inotrope and vasopressor guidelines

    Medication

    Prescribe

    Make infusion using

    Volume to be removed from bag

    Suggested dosing range

    Adrenaline (epinephrine)

    1 mg/1 mL vials

    (1:1000)

    6 mg in 100 mL

    12 mg in 200 mL

    100 mL bag glucose 5%

    250 mL bag glucose 5%

    6 mL

    62 mL

    Starting dose:
    1 - 4 microg/minute

    Usual dose range:
    1 – 20 microg/minute

    Argipressin
    (vasopressin)

    20 units/1 mL vials

    Via syringe driver:
    20 units in 20 mL

    40 units in 40 mL

    Draw up 19 mL glucose 5%

    Draw up 38 mL glucose 5%

    N/A

    N/A

    Starting dose:
    0.6 units/hour

    Usual dose range:
    0.6 – 2.4 Units/hour

    Dobutamine

    250 mg/ 20 mL vials

    250 mg in 42 mL

    500 mg in 83 mL

    50 mL bag glucose 5%

    100 mL bag glucose 5%

    28 mL

    57 mL

    Starting dose:
    100 – 400 microg/minute

    Usual dose range:
    100 – 1500 microg/minute

    Dopamine

    200 mg/ 5 mL vials

    300 mg in 50 mL

    600 mg in 100 mL

    50 mL bag glucose 5%

    100 mL bag glucose 5%

    7.5 mL

    15 mL

    Starting dose:
    100 – 400 microg/minute

    Usual dose range:
    100 – 1500 microg/minute

    Isoprenaline

    1 mg/ 5 mL vials

    6 mg in 100 mL

    100 mL bag glucose 5%

    30 mL

    Starting dose:
    0.5 – 2 microg/minute

    Usual dose range:
    2 – 10 microg/minute

    Levosimendan

    12.5 mg/ 5 mL vials

    12.5 mg in 250 mL

    250 mL bag glucose 5%

    5 mL

    Usual dose range:
    0.05 – 0.2 microg/kg/minute

    Metaraminol

    10 mg/ 1 mL vials

    Incremental IV bolus:
    10 mg in 20 mL

    Via syringe driver:
    20 mg in 40 mL

    Draw up 19 mL glucose 5%

    Draw up 38 mL glucose 5%

    N/A

    N/A

    Usual dose range:
    0.5 – 10 mg/hour

    Milrinone

    10 mg/ 10 mL vials

    Via syringe driver:
    10 mg in 50 mL

    Via infusion pump:
    20 mg in 100 mL

    Draw up 40 mL glucose 5%

    100 ml bag glucose 5%

    N/A

    20 mL

    Starting dose:
    0.1 microg/kg/minute

    Usual dose range:
    0.125 – 0.75 microgram/kg/minute

    Noradrenaline
    (norepinephrine)

     

    2 mg/ 2 mL vials

    4mg in 66mL

    6mg in 100 mL

    16 mg in 266 mL

    100mL bag glucose 5%

    100 mL bag glucose 5%

    250 mL bag glucose 5%

    38mL

    6 mL

    Nil

     

    Starting dose:
    2 – 10 microg/minute

    Usual dose range:
    0.5 - 30 microg/minute

    Implement the guidelines in your health service

    Download our change package

    This document is designed to help you implement the above guidelines.

    It contains strategies and resources to help you manage change at your service.

    Watch our webinar to learn more.

    Are you using the guidelines in your health service? Take our survey and share your feedback.

    Test your knowledge

    Download our learning package.

    This package is for nurses, and junior medical and allied health staff who are transitioning to ICUs and CCUs.

    It outlines actions, clinical effects, indications and clinical considerations. 

    Background

    Inotropes and vasopressors are vital medicines that are commonly used to treat the heart – mostly in our hospitals’ intensive care units (ICUs) or critical care units (CCUs).

    Research shows the way they are used varies significantly between health services.

    To help reduce medication errors and support consistent, high-quality care for all Victorian patients, we have released standardised guidelines on how centrally administered inotropes and vasopressors are prepared, dosed and administered.

    Read more about this project

    Get in touch

    Clinical Guidance Team
    Safer Care Victoria

    Version history

    Last reviewed: December 2018
    Due for review: December 2021

    Was this content helpful to you?